
University of Western Australia
Challenges students to reach their potential.
Fair, constructive, and always motivating.
Creates a collaborative and inclusive space.
Always goes above and beyond for students.
Inspires students to reach new heights.
Dr Aron Chakera is a renal physician and transplant specialist affiliated with the University of Western Australia Medical School and Sir Charles Gairdner Hospital in Perth. He graduated with MBBS (Honours) from the University of Western Australia and was selected as a Western Australian Rhodes Scholar in 2001. He completed his DPhil and specialist training in renal medicine at the University of Oxford, United Kingdom, acquiring qualifications including MRCP(UK), FRCP, FRACP, FHEA, and PGDipLATHE. Returning to Western Australia in 2012, he joined Sir Charles Gairdner Hospital as a consultant nephrologist. In 2015, he was appointed Director of Research for the Sir Charles Gairdner and Osborne Park Health Care Group. As Group Leader of the Translational Renal Research Group at the Harry Perkins Institute of Medical Research, he serves as clinical lead for peritoneal dialysis and autoimmune kidney diseases, and co-lead for transplantation services.
Dr Chakera's research focuses on immune function, host-pathogen interactions, and epidemiology in renal medicine. He heads laboratory-based discovery science extending to clinical applications and serves as principal investigator on more than 30 clinical trials. His work has driven changes in clinical practice, policy, and new models of care adopted locally and nationally. Notable contributions include developments in rapid antibiotic resistance testing and phage therapy platforms, supported by competitive grants such as nearly $500,000 for fungal detection tests. Key publications encompass high-impact papers such as 'Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial' (2023, cited 268 times), 'Sparsentan in patients with IgA nephropathy: a prespecified interim analysis' (2023, cited 243 times), and 'Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression' (2016, cited 103 times). With an h-index of 23 and over 2,613 citations, his research significantly influences nephrology, particularly in IgA nephropathy, ANCA-associated vasculitis, and transplant immunology.
Professional Email: aron.chakera@uwa.edu.au